Sakura Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.7M
- Investors
-
2
Sakura Bio General Information
Description
Developer of an allogeneic T and NK cell therapy designed to fight cancer. The company offers a T and NK cell population with enhanced potency, persistence, and resistance to the tumor microenvironment, enabling patients with durable anti-tumor activity with minimal toxicity to healthy tissue.
Contact Information
Website
www.sakurabio.comCorporate Office
- High-Tech Village Givat Ram Campus
- Jerusalem
- Israel
Corporate Office
- High-Tech Village Givat Ram Campus
- Jerusalem
- Israel
Sakura Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-May-2025 | $1.7M | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | 01-Jan-2022 | Completed | Pre-Clinical Trials |
Sakura Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sakura Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sakura Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hadasit | Venture Capital | Minority | ||
| VLX Ventures | Venture Capital | Minority |
Sakura Bio FAQs
-
When was Sakura Bio founded?
Sakura Bio was founded in 2022.
-
Where is Sakura Bio headquartered?
Sakura Bio is headquartered in Jerusalem, Israel.
-
What is the size of Sakura Bio?
Sakura Bio has 3 total employees.
-
What industry is Sakura Bio in?
Sakura Bio’s primary industry is Biotechnology.
-
Is Sakura Bio a private or public company?
Sakura Bio is a Private company.
-
What is Sakura Bio’s current revenue?
The current revenue for Sakura Bio is .
-
How much funding has Sakura Bio raised over time?
Sakura Bio has raised $1.7M.
-
Who are Sakura Bio’s investors?
Hadasit and VLX Ventures have invested in Sakura Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
